BIO President & CEO James Greenwood published an op-ed piece in yesterday’s USA Today on how “patents promote innovation”:
Public debate over access to, and use of, genetic technology is a good thing. It requires the consideration of many factors, including coverage and cost, concerns over genetic discrimination and myriad regulatory issues.
Even so, banning patents on gene-related breakthroughs would slow biomedical innovation to a halt — taking away the hope biotechnology offers to patients suffering from debilitating diseases such as cancer, Parkinson’s and HIV/AIDS — while doing nothing to address what is really a much more complicated set of issues.
You can post a comment (we assume you have one) at USA Today, and take PatentlyBIOtech’s poll below: